156 related articles for article (PubMed ID: 30061938)
1. Prognostic role of multidrug resistance-associated protein 1 expression and platelet count in operable non-small cell lung cancer.
Fang L; Sheng H; Wan D; Zhu C; Jiang R; Sun X; Feng J
Oncol Lett; 2018 Jul; 16(1):1123-1132. PubMed ID: 30061938
[TBL] [Abstract][Full Text] [Related]
2. Integrin-Linked Kinase, Snail and Multidrug Resistance Protein 1: Three concordant players in the progression of non-small cell lung cancer.
Abd El-Rehim DM; Abd-Elghany MI; Nazmy MH
J Egypt Natl Canc Inst; 2015 Sep; 27(3):129-37. PubMed ID: 25964055
[TBL] [Abstract][Full Text] [Related]
3. Preoperative platelet count improves the prognostic prediction of the FIGO staging system for operable cervical cancer patients.
Zheng RR; Huang XX; Jin C; Zhuang XX; Ye LC; Zheng FY; Lin F
Clin Chim Acta; 2017 Oct; 473():198-203. PubMed ID: 27836106
[TBL] [Abstract][Full Text] [Related]
4. Clinical relevance of the multidrug resistance‑associated protein 1 gene in non‑small cell lung cancer: A systematic review and meta‑analysis.
Hu P; Wong PT; Zhou Q; Sheng L; Niu W; Chen S; Xu M; Lin Y
Oncol Rep; 2018 Nov; 40(5):3078-3091. PubMed ID: 30132569
[TBL] [Abstract][Full Text] [Related]
5. The preoperative hemoglobin, albumin, lymphocyte, and platelet score is a prognostic factor for non-small cell lung cancer patients undergoing adjuvant chemotherapy: a retrospective study.
Wei S; Shao J; Wang J; Wang G
Ann Transl Med; 2022 Apr; 10(8):457. PubMed ID: 35571436
[TBL] [Abstract][Full Text] [Related]
6. Platelet Count as a Prognostic Factor in Stage IV Non-Small Cell Lung Cancer.
Saha B; Khatun N; Azim N; Islam SA; Proteek MF; Islam MR; Begum FA; Biddut MA; Khan MK; Islam MR
Mymensingh Med J; 2022 Oct; 31(4):937-946. PubMed ID: 36189536
[TBL] [Abstract][Full Text] [Related]
7. Expression of MRP1, BCRP, LRP and ERCC1 as prognostic factors in non-small cell lung cancer patients receiving postoperative cisplatin-based chemotherapy.
Li XQ; Li J; Shi SB; Chen P; Yu LC; Bao QL
Int J Biol Markers; 2009; 24(4):230-7. PubMed ID: 20082278
[TBL] [Abstract][Full Text] [Related]
8. Expression of MRP1, BCRP, LRP, and ERCC1 in advanced non-small-cell lung cancer: correlation with response to chemotherapy and survival.
Li J; Li ZN; Du YJ; Li XQ; Bao QL; Chen P
Clin Lung Cancer; 2009 Nov; 10(6):414-21. PubMed ID: 19900859
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of combination of preoperative platelet count and mean platelet volume in patients with resectable non-small cell lung cancer.
Gao L; Zhang H; Zhang B; Zhang L; Wang C
Oncotarget; 2017 Feb; 8(9):15632-15641. PubMed ID: 28152504
[TBL] [Abstract][Full Text] [Related]
10. Preoperative platelet count in predicting lymph node metastasis and prognosis in patients with non-small cell lung cancer.
Liu HB; Gu XL; Ma XQ; Lv TF; Wu Y; Xiao YY; Yuan DM; Li YF; Song Y
Neoplasma; 2013; 60(2):203-8. PubMed ID: 23259790
[TBL] [Abstract][Full Text] [Related]
11. Platelet count predicts prognosis in operable non-small cell lung cancer.
Yu D; Liu B; Zhang L; DU K
Exp Ther Med; 2013 May; 5(5):1351-1354. PubMed ID: 23737877
[TBL] [Abstract][Full Text] [Related]
12. Association of expression of MRP1, BCRP, LRP and ERCC1 with outcome of patients with locally advanced non-small cell lung cancer who received neoadjuvant chemotherapy.
Li J; Li ZN; Yu LC; Bao QL; Wu JR; Shi SB; Li XQ
Lung Cancer; 2010 Jul; 69(1):116-22. PubMed ID: 19875192
[TBL] [Abstract][Full Text] [Related]
13. NQO1 protein expression predicts poor prognosis of non-small cell lung cancers.
Li Z; Zhang Y; Jin T; Men J; Lin Z; Qi P; Piao Y; Yan G
BMC Cancer; 2015 Mar; 15():207. PubMed ID: 25880877
[TBL] [Abstract][Full Text] [Related]
14. Multidrug resistance markers P-glycoprotein, multidrug resistance protein 1, and lung resistance protein in non-small cell lung cancer: prognostic implications.
Berger W; Setinek U; Hollaus P; Zidek T; Steiner E; Elbling L; Cantonati H; Attems J; Gsur A; Micksche M
J Cancer Res Clin Oncol; 2005 Jun; 131(6):355-63. PubMed ID: 15856298
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of the resistance proteins LRP, Pgp, MRP1, MRP3, and MRP5 in epithelial ovarian cancer.
Sedláková I; Laco J; Caltová K; Červinka M; Tošner J; Řezáč A; Špaček J
Int J Gynecol Cancer; 2015 Feb; 25(2):236-43. PubMed ID: 25594141
[TBL] [Abstract][Full Text] [Related]
16. Expression levels of HER2 and MRP1 are not prognostic factors of long-term survival in 829 patients with esophageal squamous cell carcinoma.
Chen Y; Zhu SM; Xu XL; Zhao AN; Hu JL
Oncol Lett; 2016 Jan; 11(1):745-752. PubMed ID: 26870278
[TBL] [Abstract][Full Text] [Related]
17. Role of increased mean platelet volume (MPV) and decreased MPV/platelet count ratio as poor prognostic factors in lung cancer.
Omar M; Tanriverdi O; Cokmert S; Oktay E; Yersal O; Pilancı KN; Menekse S; Kocar M; Sen CA; Ordu C; Goksel G; Meydan N; Barutca S;
Clin Respir J; 2018 Mar; 12(3):922-929. PubMed ID: 28026133
[TBL] [Abstract][Full Text] [Related]
18. Preoperative systemic immune-inflammation index predicts prognosis and guides clinical treatment in patients with non-small cell lung cancer.
Yan X; Li G
Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32175568
[TBL] [Abstract][Full Text] [Related]
19. Elevated platelet count is a strong predictor of poor prognosis in stage I non-small cell lung cancer patients.
Ji Y; Sheng L; Du X; Qiu G; Su D
Platelets; 2015; 26(2):138-42. PubMed ID: 24679181
[TBL] [Abstract][Full Text] [Related]
20. Pretreatment Platelet Count is a Prognostic Marker in Lung Cancer: A Danish Registry-based Cohort Study.
Sandfeld-Paulsen B; Aggerholm-Pedersen N; Winther-Larsen A
Clin Lung Cancer; 2023 Mar; 24(2):175-183. PubMed ID: 36646586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
